BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19188866)

  • 21. The solubility of calcium and phosphorus in neonatal total parenteral nutrition solutions.
    Dunham B; Marcuard S; Khazanie PG; Meade G; Craft T; Nichols K
    JPEN J Parenter Enteral Nutr; 1991; 15(6):608-11. PubMed ID: 1766049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium and phosphate solubility curves for parenteral nutrient solutions containing aminoplasmal-paed, Aminovenos-N-pad or Moripron-F.
    Mo-Suwan L; Apiromrak B; Puetpaiboon A
    J Med Assoc Thai; 1993 Dec; 76(12):688-92. PubMed ID: 7798821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of high calcium and phosphate concentrations on the physicochemical properties of two lipid emulsions used as total parenteral nutrition for neonates.
    Chaieb SD; Chaumeil JC; Jebnoun S; Khrouf N; Hedhili A; Sfar S
    PDA J Pharm Sci Technol; 2009; 63(1):27-41. PubMed ID: 19455940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The solubility of calcium and phosphate in two specialty amino acid solutions.
    MacKay MW; Fitzgerald KA; Jackson D
    JPEN J Parenter Enteral Nutr; 1996; 20(1):63-6. PubMed ID: 8788265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compatibility considerations in parenteral nutrient solutions.
    Niemiec PW; Vanderveen TW
    Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compatibility of Maximum Inorganic and Organic Calcium and Phosphate Content in Neonatal Parenteral Solutions.
    Watrobska-Swietlikowska D
    Sci Rep; 2019 Jul; 9(1):10525. PubMed ID: 31324864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of famotidine 20 and 40 mg/L and amino acids in total parenteral nutrient solutions.
    Bullock L; Fitzgerald JF; Glick MR; Parks RB; Schnabel JG; Hancock BG
    Am J Hosp Pharm; 1989 Nov; 46(11):2321-5. PubMed ID: 2511752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maximization of calcium and phosphate in neonatal total parenteral nutrition.
    Maruyama H; Saito J; Nagai M; Mochizuki M; Ishikawa Y; Ito Y
    Pediatr Int; 2018 Jul; 60(7):634-638. PubMed ID: 29654605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organic phosphates in parenteral nutrition: pouring fresh water into an old bucket.
    Ronchera-oms CL; Allwood MC; Hardy G
    Nutrition; 1996 May; 12(5):388-9. PubMed ID: 8875531
    [No Abstract]   [Full Text] [Related]  

  • 30. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium chloride and sodium phosphate in neonatal parenteral nutrition containing TrophAmine: precipitation studies and aluminum content.
    Migaki EA; Melhart BJ; Dewar CJ; Huston RK
    JPEN J Parenter Enteral Nutr; 2012 Jul; 36(4):470-5. PubMed ID: 22245762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth of bacteria and fungi in parenteral nutrition solutions containing albumin.
    Mirtallo JM; Caryer K; Schneider PJ; Ayers L; Fabri PJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1907-10. PubMed ID: 6798862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy.
    Akers MJ; Schrank GD; Russell S
    Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn PF or TrophAmine.
    Mikrut BA
    Am J Hosp Pharm; 1987 Dec; 44(12):2702-4. PubMed ID: 3124615
    [No Abstract]   [Full Text] [Related]  

  • 35. Calcium chloride in neonatal parenteral nutrition: compatibility studies using laser methodology.
    Huston RK; Christensen JM; Karnpracha C; Rosa JE; Clark SM; Migaki EA; Wu Y
    PLoS One; 2014; 9(9):e106825. PubMed ID: 25192060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Calcium and phosphates compatibilities in parenteral nutrition admixtures].
    Driss Chaieb S; Sfar S; Chaumeil JC
    Tunis Med; 2006 Nov; 84(11):677-82. PubMed ID: 17294890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of parenteral nutrition admixtures containing organic phosphates.
    Ronchera-Oms CL; Jiménez NV; Peidro J
    Clin Nutr; 1995 Dec; 14(6):373-80. PubMed ID: 16843959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of sodium glycerophosphate in neonatal parenteral nutrition solutions to increase calcium and phosphate compatibility for preterm infants.
    Wang HJ; Hsieh YT; Liu LY; Huang CF; Lin SC; Tsao PN; Chou HC; Yen TA; Chen CY
    Pediatr Neonatol; 2020 Jun; 61(3):331-337. PubMed ID: 32199865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probability-based compatibility curves for calcium and phosphates in parenteral nutrition formulations.
    Gonyon T; Carter PW; Phillips G; Owen H; Patel D; Kotha P; Green JB
    JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):717-27. PubMed ID: 23894169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dosage of calcium and phosphate in parenteral feeding].
    Berg G; Matzkies F; Waldherr A; Fekl W
    Infusionsther Klin Ernahr; 1978 Apr; 5(2):69-72. PubMed ID: 418004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.